Literature DB >> 12027820

Preoperative serum SCC, CA125, and CA19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix.

Mahito Takeda1, Noriaki Sakuragi, Kazuhira Okamoto, Yukiharu Todo, Shin-Ichiro Minobe, Eiji Nomura, Hiroaki Negishi, Mamoru Oikawa, Ritsu Yamamoto, Seiichiro Fujimoto.   

Abstract

BACKGROUND: We wanted to investigate the clinical usefulness of determining the pretreatment levels of multiple serum tumor markers in predicting lymph node status and the prognosis for patients with cervical carcinoma.
METHODS: The preoperative serum levels of squamous cell carcinoma antigen (SCC), cancer antigens CA125 and CA19-9 were assayed simultaneously in 103 patients with stages IB to IIB cervical SCC undergoing radical hysterectomy. The cut-off values of SCC, CA125, and CA19-9 in this study were 1.5 ng/ml, 35 U/ml, and 37 U/ml, respectively. The relation between preoperative tumor marker levels and histopathologic prognostic factors including lymph node metastasis and patient survival was studied.
RESULTS: Preoperative serum SCC, CA125, and CA19-9 levels were significantly related to the FIGO stage. In addition, serum SCC and CA125 levels were significantly related to tumor diameter, depth of cervical stromal invasion, lymph-vascular space invasion, and lymph node metastasis. We subsequently created a double-tumor-marker (DTM) index, which incorporated the number of positive markers of SCC and CA125. The DTM index was strongly related to the number of positive pelvic lymph nodes (p = 0.0002) and to the site of positive nodes (none vs. pelvic only vs. common iliac/paraaortic) (p = 0.0005). Probability of lymph node metastasis according to the DTM index = 0, 1, and 2 was 6/48 (12.5%), 14/45 (31.1%), and 8/10 (80.0%), respectively. The rate of common iliac/paraaortic node metastasis according to the DTM index = 0, 1, and 2 was 1/48 (2.1%), 2/45 (4.4%), and 3/10 (30.0%), respectively. By logistic regression analysis, it was shown that the DTM index and tumor diameter were independently related to lymph node metastasis. Using multivariate Cox regression analysis including singly determined serum SCC and CA125 levels, clinical stage (IB/IIA vs. IIB), tumor diameter (<or= 2 vs. 2-4 vs. > 4 cm), parametrial invasion, lymph node metastasis, and the DTM index, the DTM index was found to be the most important prognostic factor (p = 0.0005). However, when the sites of positive nodes were included in the multivariate analysis, only the sites of positive nodes (p = 0.0008) and parametrial invasion (p = 0.041) showed independent prognostic significance.
CONCLUSION: Combination assay of pretreatment serum SCC and CA125 levels seems to be useful in estimating lymph node status and the prognosis for patients with cervical SCC in a preoperative setting.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12027820     DOI: 10.1034/j.1600-0412.2002.810513.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  22 in total

Review 1.  Up-to-date management of lymph node metastasis and the role of tailored lymphadenectomy in cervical cancer.

Authors:  Noriaki Sakuragi
Journal:  Int J Clin Oncol       Date:  2007-06-27       Impact factor: 3.402

2.  Integrative analysis of DNA methylation and gene expression identified cervical cancer-specific diagnostic biomarkers.

Authors:  Wanxue Xu; Mengyao Xu; Longlong Wang; Wei Zhou; Rong Xiang; Yi Shi; Yunshan Zhang; Yongjun Piao
Journal:  Signal Transduct Target Ther       Date:  2019-12-13

3.  Cancer of the cervix - from bleak past to bright future; a review, with an emphasis on cancer of the cervix in malaysia.

Authors:  Othman Nor Hayati
Journal:  Malays J Med Sci       Date:  2003-01

4.  The SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) and serum squamous cell carcinoma antigen (SCC-ag) function as prognostic biomarkers in patients with primary cervical cancer.

Authors:  LingLing Pan; JingYi Cheng; Min Zhou; ZhiFeng Yao; YingJian Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2011-11-20       Impact factor: 4.553

5.  Tumor size and lymph node status determined by imaging are reliable factors for predicting advanced cervical cancer prognosis.

Authors:  Min Sun Kyung; Hong Bae Kim; Jung Yeob Seoung; In Young Choi; Young Soo Joo; Me Yeon Lee; Jung Bae Kang; Young Han Park
Journal:  Oncol Lett       Date:  2015-03-05       Impact factor: 2.967

Review 6.  Human papillomavirus and cervical cancer: an insight highlighting pathogenesis and targeting strategies.

Authors:  Prachi S Ojha; Meenaxi M Maste; Siddarth Tubachi; Vishal S Patil
Journal:  Virusdisease       Date:  2022-05-30

7.  Squamous cell carcinoma antigen in lung cancer and nonmalignant respiratory diseases.

Authors:  Katsunori Kagohashi; Hiroaki Satoh; Koichi Kurishima; Kennosuke Kadono; Hiroichi Ishikawa; Morio Ohtsuka; Kiyohisa Sekizawa
Journal:  Lung       Date:  2008-07-29       Impact factor: 2.584

8.  Relationship between pre-treatment serum SCC (squamous cell carcinoma) antigen, Cyfra 21-1 levels, and survival in squamous cell carcinoma of the uterine cervix.

Authors:  Ki-Hong Chang; Hee-Sug Ryu; Suk-Joon Chang; Young-Ji Byun; Jung-Pil Lee
Journal:  Cancer Res Treat       Date:  2005-10-31       Impact factor: 4.679

Review 9.  Clinical Trials of Antiangiogenesis Therapy in Recurrent/Persistent and Metastatic Cervical Cancer.

Authors:  Jill K Alldredge; Krishnansu S Tewari
Journal:  Oncologist       Date:  2016-03-29

10.  Multivariate prognostic analysis of adenocarcinoma of the uterine cervix treated with radical hysterectomy and systematic lymphadenectomy.

Authors:  Tatsuya Kato; Hidemichi Watari; Mahito Takeda; Masayoshi Hosaka; Takashi Mitamura; Noriko Kobayashi; Satoko Sudo; Masanori Kaneuchi; Masataka Kudo; Noriaki Sakuragi
Journal:  J Gynecol Oncol       Date:  2013-07-04       Impact factor: 4.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.